Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 2939370, 15 pages
http://dx.doi.org/10.1155/2016/2939370
Research Article

SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis)

1Molecular Immunology Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
3Immunoregulation Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
4Department of Microbiology & Cell Science, University of Florida, Gainesville, FL 32611, USA

Received 26 February 2016; Revised 12 May 2016; Accepted 7 June 2016

Academic Editor: Hannes Neuwirt

Copyright © 2016 Chang He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Nussenblatt, “The natural history of uveitis,” International Ophthalmology, vol. 14, no. 5-6, pp. 303–308, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Nussenblatt, “Bench to bedside: new approaches to the immunotherapy of uveitic disease,” International Reviews of Immunology, vol. 21, no. 2-3, pp. 273–289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. R. Caspi, “A look at autoimmunity and inflammation in the eye,” The Journal of Clinical Investigation, vol. 120, no. 9, pp. 3073–3083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R.-X. Wang, C.-R. Yu, R. M. Mahdi, and C. E. Egwuagu, “Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells,” Journal of Biological Chemistry, vol. 287, no. 43, pp. 36012–36021, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R.-X. Wang, C.-R. Yu, I. M. Dambuza et al., “Interleukin-35 induces regulatory B cells that suppress autoimmune disease,” Nature Medicine, vol. 20, no. 6, pp. 633–641, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Amadi-Obi, C.-R. Yu, X. Liu et al., “TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1,” Nature Medicine, vol. 13, pp. 711–718, 2007. View at Publisher · View at Google Scholar
  7. D. Luger, P. B. Silver, J. Tang et al., “Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category,” The Journal of Experimental Medicine, vol. 205, no. 4, pp. 799–810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Liu, S. L. Yun, C.-R. Yu, and C. E. Egwuagu, “Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases,” Journal of Immunology, vol. 180, no. 9, pp. 6070–6076, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Egwuagu and J. Larkin III, “Therapeutic targeting of STAT pathways in CNS autoimmune diseases,” JAK-STAT, vol. 2, no. 1, Article ID e24134, 2013. View at Publisher · View at Google Scholar
  10. C. E. Egwuagu, “STAT3 in CD4+ T helper cell differentiation and inflammatory diseases,” Cytokine, vol. 47, no. 3, pp. 149–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. W. S. Alexander and D. J. Hilton, “The role of Suppressors of Cytokine Signaling (SOCS) proteins in regulation of the immune response,” Annual Review of Immunology, vol. 22, pp. 503–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Hilton, “Negative regulators of cytokine signal transduction,” Cellular and Molecular Life Sciences, vol. 55, no. 12, pp. 1568–1577, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Yasukawa, A. Sasaki, and A. Yoshimura, “Negative regulation of cytokine signaling pathways,” Annual Review of Immunology, vol. 18, pp. 143–164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Jo, D. Liu, S. Yao, R. D. Collins, and J. Hawiger, “Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis,” Nature Medicine, vol. 11, no. 8, pp. 892–898, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. D. Jager, R. Dabelic, L. W. Waiboci et al., “The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis,” Journal of Neuroimmunology, vol. 232, no. 1-2, pp. 108–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. R. Caspi, P. B. Silver, C.-C. Chan et al., “Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response,” The Journal of Immunology, vol. 157, no. 6, pp. 2668–2675, 1996. View at Google Scholar · View at Scopus
  17. R. R. Caspi, “Experimental autoimmune uveoretinitis in the rat and mouse,” in Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevech, and W. Strober, Eds., chapter 15: unit 15.6.1–15.6.20, John Wiley & Sons, 2003. View at Google Scholar
  18. R. K. Agarwal, P. B. Silver, and R. R. Caspi, “Rodent models of experimental autoimmune uveitis,” Methods in Molecular Biology, vol. 900, pp. 443–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. U. C. S. Yadav, M. Sboeb, S. K. Srivstava, and K. V. Ramana, “Ameliorate of experimental autoimmune uveoretinitis by aldos reductase inhibition in Lewis Tats,” Investigative Ophthalmology & Visual Science, vol. 52, pp. 8033–8041, 2011. View at Google Scholar
  20. C. He, C.-R. Yu, L. Sun, R. M. Mahdi, J. Larkin, and C. E. Egwuagu, “Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis,” Journal of Autoimmunity, vol. 62, pp. 31–38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Shao, S. Lei, S. L. Sun, H. J. Kaplan, and D. Sun, “Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets,” Journal of Immunology, vol. 171, no. 10, pp. 5624–5630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Diedrichs-Möhring, C. Hoffmann, and G. Wildner, “Antigen-dependent monophasic or recurrent autoimmune uveitis in rats,” International Immunology, vol. 20, no. 3, pp. 365–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Shao, H. Shi, H. J. Kaplan, and D. Sun, “Chronic recurrent autoimmune uveitis with progressive photoreceptor damage induced in rats by transfer of IRBP-specific T cells,” Journal of Neuroimmunology, vol. 163, no. 1-2, pp. 102–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Yoshida, R. Yoshimi, H. Yoshii et al., “The transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation,” Immunity, vol. 40, no. 2, pp. 187–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Takase, C.-R. Yu, X. Liu, C. Fujimoto, I. Gery, and C. E. Egwuagu, “Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins,” Journal of Neuroimmunology, vol. 168, no. 1-2, pp. 118–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-R. Yu, R. M. Mahdi, S. Ebong et al., “Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling,” Journal of Immunology, vol. 173, no. 2, pp. 737–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-R. Yu, R. M. Mahdi, S. Ebong, B. P. Vistica, I. Gery, and C. E. Egwuagu, “Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells,” Journal of Biological Chemistry, vol. 278, no. 32, pp. 29752–29759, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-R. Yu, R. R. Mahdi, H.-M. Oh et al., “Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation,” Investigative Ophthalmology & Visual Science, vol. 52, no. 9, pp. 6978–6986, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. E. Egwuagu, L. Sun, S. H. Kim, and I. M. Dambuza, “Ocular inflammatory diseases: molecular pathogenesis and immunotherapy,” Current Molecular Medicine, vol. 15, no. 6, pp. 517–528, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-R. Yu, K. Hayashi, Y. S. Lee et al., “Suppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infection,” Inflammation, vol. 38, no. 2, pp. 555–565, 2015. View at Publisher · View at Google Scholar · View at Scopus